Last reviewed · How we verify
NCT07448558: TAILOR-Ex
Tailored Exercise to Reduce Aromatase Inhibitor Associated Musculoskeletal Symptoms
NA trial testing tailored exercise in Patients With Early Breast Cancer Who Initiating Adjuvant Aromatase Inhibitor in 206 participants. Currently enrolling.
18 February 2029
Quick facts
| Lead sponsor | Mahidol University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 206 |
| Start date | 18 February 2026 |
| Primary completion | 18 February 2029 |
| Estimated completion | 18 August 2029 |
| Sites | 1 location across Thailand |
Drugs / interventions tested
- tailored exercise
Conditions studied
- Patients With Early Breast Cancer Who Initiating Adjuvant Aromatase Inhibitor — all drugs for Patients With Early Breast Cancer Who Initiating Adjuvant Aromatase Inhibitor →
Sponsor
Mahidol University
Who can join
18 and older, any sex, with Patients With Early Breast Cancer Who Initiating Adjuvant Aromatase Inhibitor. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A randomized controlled study evaluating effect of tailored exercise compared to routine practice as a preventive measure of aromatase inhibitor associated musculoskeletal related symptoms in early breast cancer patients
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07448558
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Mahidol University trials
Trials by the same sponsor.
- NCT07568496 — Greater Occipital Nerve Block for Migraine With Medication Overuse Headache · NA · not yet recruiting
- NCT07407400 — Lemborexant for Sleep and Delirium Prevention in Elderly ICU Patients · Phase 4 · not yet recruiting
- NCT07378501 — Thai Version of the Pediatric Quality of Recovery Score (PedSQoR): Translation and Psychometric Validation Study · not yet recruiting
- NCT07438301 — Septic Shock Hemodynamic Respond to Volume Resuscitation Versus Vasopressor Administration · not yet recruiting
- NCT07390006 — Enabling Patient-Reported Outcomes Through Innovative Care - ACS (EPIC-ACS) · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07448558 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mahidol University
- Last refreshed: 4 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07448558.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing